FGFR3 is also implicated in various cancers, including bladder and cervical cancer. Histopathological studies reveal that overexpression or mutation of FGFR3 can lead to uncontrolled cell proliferation and tumor development. In bladder cancer, for instance, FGFR3 mutations are often found in low-grade, non-invasive tumors, suggesting a role in early-stage tumorigenesis.
